Mountain Crest Acquisition Corp. V has reported a net loss of $431,161 for the fiscal year ending December 31, 2025, compared to a net loss of $374,454 in the previous year. The company's total assets decreased to $873,566 from $1,314,091, primarily due to a reduction in investments held in the Trust Account, which fell to $840,639 from $1,157,312. The decrease in assets and the increase in losses were attributed to higher general and administrative expenses, which amounted to $471,782, down from $618,486 in 2024. The company has not generated any operating revenue, as it remains focused on identifying a target for its initial business combination.
Significant operational changes included the termination of a proposed business combination with AUM Biosciences in June 2023, which led to the cancellation of a special stockholder meeting. Following this, the company extended its business combination deadline to November 16, 2026, by depositing $51,932 into its Trust Account. The company has also faced compliance challenges with Nasdaq, including a failure to meet the market value of listed securities requirement, but successfully regained compliance by June 2024.
Mountain Crest Acquisition Corp. V has been actively managing its financial obligations, including issuing several promissory notes to its sponsor, totaling up to $1.5 million. As of December 31, 2025, the company had $11,909 in cash held outside the Trust Account for working capital purposes. The company’s management has indicated that it may need to raise additional capital to finance transaction costs related to its business combination efforts.
Looking ahead, the company is pursuing a business combination with CUBEBIO Co., Ltd., a Korea-based company, which is expected to be completed by May 15, 2025. The company has expressed confidence in its ability to complete this transaction, although it acknowledges the uncertainty surrounding the completion of any business combination by the extended deadline. The management remains focused on identifying suitable acquisition targets in North America and the Asia Pacific regions, excluding China, and is committed to enhancing its operational capabilities to facilitate a successful merger.
About Mountain Crest Acquisition Corp. V
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.